{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:14:18Z","timestamp":1783131258350,"version":"3.54.6"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s12010-017-2625-y","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T22:27:02Z","timestamp":1508797622000},"page":"1421-1440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Discovery of Potent Neuraminidase Inhibitors Using a Combination of Pharmacophore-Based Virtual Screening and Molecular Simulation Approach"],"prefix":"10.1007","volume":"184","author":[{"given":"Rohini","family":"K","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanthi","family":"V","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"key":"2625_CR1","doi-asserted-by":"crossref","first-page":"e28111","DOI":"10.1371\/journal.pone.0028111","volume":"6","author":"XB Li","year":"2011","unstructured":"Li, X. B., Wang, S. Q., Xu, W. R., Wang, R. L., & Chou, K. C. (2011). Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping method. PLoS One, 6, e28111.","journal-title":"PLoS One"},{"key":"2625_CR2","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1099\/vir.0.83129-0","volume":"88","author":"MM Mukhtar","year":"2007","unstructured":"Mukhtar, M. M., Rasool, S. T., Song, D., Zhu, C., Hao, Q., & Zhu, Y. (2007). Origin of highly pathogenic H5N1 avian influenza virus in China and genetic characterization of donor and recipient viruses. Journal of General Virology, 88, 3094\u20133099.","journal-title":"Journal of General Virology"},{"key":"2625_CR3","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1128\/JVI.78.22.12665-12667.2004","volume":"78","author":"MN Matrosovich","year":"2004","unstructured":"Matrosovich, M. N., Matrosovich, T. Y., Gray, T., Roberts, N. A., & Klenk, H. (2004). Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. Journal of Virology, 78, 12665\u201312667.","journal-title":"Journal of Virology"},{"key":"2625_CR4","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1007\/s00705-008-0255-y","volume":"153","author":"Y Su","year":"2008","unstructured":"Su, Y., Yang, H. Y., Zhang, B. J., Jia, H. L., & Tien, P. (2008). Analysis of a point mutation in H5N1 avian influenza virus hemagglutinin in relation to virus entry into live mammalian cells. Archives of Virology, 153, 2253\u20132261.","journal-title":"Archives of Virology"},{"key":"2625_CR5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1465-9921-6-135","volume":"6","author":"MC Chan","year":"2005","unstructured":"Chan, M. C., Cheung, C. Y., Chui, W. H., Tsao, S. W., Nicholls, J. M., Chan, Y. O., Chan, R. W., Long, H. T., Poon, L. L., Guan, Y., & Peiris, J. S. (2005). Pro-inflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respiratory Research, 6, 135.","journal-title":"Respiratory Research"},{"key":"2625_CR6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.antiviral.2009.01.006","volume":"82","author":"K Bauer","year":"2009","unstructured":"Bauer, K., Richter, M., Wutzler, P., & Schmidtke, M. (2009). Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005\/06. Antiviral Research, 82, 34\u201341.","journal-title":"Antiviral Research"},{"key":"2625_CR7","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.2165\/11531450-000000000-00000","volume":"69","author":"AC Hurt","year":"2009","unstructured":"Hurt, A. C., Holien, J. K., Parker, M., & Barr, I. G. (2009). Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses. Drugs, 69, 2523\u20132531.","journal-title":"Drugs"},{"key":"2625_CR8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s10156-012-0428-1","volume":"18","author":"Y Shobugawa","year":"2012","unstructured":"Shobugawa, Y., Saito, R., Sato, I., Kawashima, T., Dapat, C., Dapat, I. C., Kondo, H., Suzuki, Y., Saito, K., & Suzuki, H. (2012). Clinical effectiveness of neuraminidase inhibitor\u2014oseltamivir, zanamivir, laninamivir, and peramivir\u2014for treatment of influenza A(H3N2) and A(H1N1) pdm09 infection: an observational study in the 2010-2011 influenza season in Japan. Journal of Infection and Chemotherapy, 18, 858\u2013864.","journal-title":"Journal of Infection and Chemotherapy"},{"key":"2625_CR9","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1128\/AAC.02956-14","volume":"58","author":"A Pizzorno","year":"2014","unstructured":"Pizzorno, A., Abed, Y., Plante, P. L., Carbonneau, J., Baz, M., Hamelin, M. E., Corbeil, J., & Boivin, G. (2014). Evolution of oseltamivir resistance mutations in influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice. Antimicrobial Agents and Chemotherapy, 58, 6398\u20136405.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"2625_CR10","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1128\/JVI.01658-12","volume":"87","author":"NC Wu","year":"2013","unstructured":"Wu, N. C., Young, A. P., Dandekar, S., Wijersuriya, H., Al-Mawsawi, L. Q., Wu, T. T., & Sun, R. (2013). Systematic identification of H274Y compensatory mutations in influenza a virus neuraminidase by high-throughput screening. Journal of Virology, 87, 1193\u20131199.","journal-title":"Journal of Virology"},{"key":"2625_CR11","first-page":"e00396","volume":"4","author":"HL Yen","year":"2013","unstructured":"Yen, H. L., McKimm-Breschkin, J. L., Choy, K. T., Wong, D. D. Y., Cheung, P. P. H., Zhou, J., Ng, I. H., Zhu, H., Webby, R. J., Guan, Y., Webster, R. G., & Peirisa, J. S. M. (2013). Resistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R\/K viral population. MBio, 4, e00396\u2013e00313.","journal-title":"MBio"},{"key":"2625_CR12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/irv.12047","volume":"7","author":"McKimm-Breschkin","year":"2012","unstructured":"McKimm-Breschkin. (2012). Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance. Influenza and Other Respiratory Viruses, 7, 25\u201336.","journal-title":"Influenza and Other Respiratory Viruses"},{"key":"2625_CR13","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/infdis\/jiu244","volume":"210","author":"V Escuret","year":"2014","unstructured":"Escuret, V., Collins, P. J., Casalegno, J. S., Vachieri, S. G., Cattle, N., Ferraris, O., Sabatier, M., Frobert, E., Caro, V., Skehel, J. J., Gamblin, S., Valla, F., Valette, M., Ottmann, M., McCauley, J. W., Daniels, R. S., & Lina, B. (2014). A novel I221L substitution in neuraminidase confers high-level resistance to oseltamivir in influenza B viruses. The Journal of Infectious Diseases, 210, 1260\u20131269.","journal-title":"The Journal of Infectious Diseases"},{"key":"2625_CR14","doi-asserted-by":"crossref","first-page":"e37095","DOI":"10.1371\/journal.pone.0037095","volume":"7","author":"J LeGoff","year":"2012","unstructured":"LeGoff, J., Rousset, D., Abou-Jaoud\u00e9, G., Scemla, A., Ribaud, P., Mercier-Delarue, S., Caro, V., Enouf, V., Simon, F., Molina, J., & van der Werf, S. (2012). I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and Zanamivir and enhanced resistance with H275Y. PLoS One, 7, e37095.","journal-title":"PLoS One"},{"key":"2625_CR15","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s12010-009-8584-1","volume":"160","author":"V Shanthi","year":"2010","unstructured":"Shanthi, V., Ramanathan, K., & Sethumadhavan, R. (2010). Exploring the role of C-H....pi interactions on the structural stability of single chain \u201call-alpha\u201d proteins. Applied Biochemistry and Biotechnology, 160, 1473\u20131483.","journal-title":"Applied Biochemistry and Biotechnology"},{"key":"2625_CR16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12010-012-9687-7","volume":"167","author":"V Karthick","year":"2012","unstructured":"Karthick, V., Shanthi, V., Rajasekaran, R., & Ramanathan, K. (2012). Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach. Applied Biochemistry and Biotechnology, 167, 237\u2013249.","journal-title":"Applied Biochemistry and Biotechnology"},{"key":"2625_CR17","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s12010-015-1760-6","volume":"177","author":"B Preethi","year":"2015","unstructured":"Preethi, B., Shanthi, V., & Ramanathan, K. (2015). Investigation of nalidixic acid resistance mechanism in Salmonella enterica using molecular simulation techniques. Applied Biochemistry and Biotechnology, 177, 528\u2013540.","journal-title":"Applied Biochemistry and Biotechnology"},{"key":"2625_CR18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s13205-015-0336-z","volume":"6","author":"A Kumar","year":"2016","unstructured":"Kumar, A., Shanthi, V., & Ramanathan, K. (2016). Discovery of potential ALK inhibitors by virtual screening approach. 3 Biotech, 6, 21.","journal-title":"3 Biotech"},{"key":"2625_CR19","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nature03197","volume":"432","author":"BK Shoichet","year":"2004","unstructured":"Shoichet, B. K. (2004). Virtual screening of chemical libraries. Nature, 432, 862\u2013865.","journal-title":"Nature"},{"key":"2625_CR20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s12013-012-9510-7","volume":"66","author":"V Karthick","year":"2013","unstructured":"Karthick, V., Ramanathan, K., Shanthi, V., & Rajasekaran, R. (2013). Identification of potential inhibitors of H5N1 influenza A virus neuraminidase by ligand-based virtual screening approach. Cell Biochemistry and Biophysics, 66, 657\u2013669.","journal-title":"Cell Biochemistry and Biophysics"},{"key":"2625_CR21","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.biopha.2016.02.041","volume":"80","author":"M Shahlaei","year":"2016","unstructured":"Shahlaei, M., & Doosti, E. (2016). Virtual screening based on pharmacophore model followed by docking simulation studies in search of potential inhibitors for p38 map kinase. Biomedicine & Pharmacotherapy, 80, 352\u2013372.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"2625_CR22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cbi.2016.06.011","volume":"254","author":"SP Kumar","year":"2016","unstructured":"Kumar, S. P., & Jha, P. C. (2016). Multi-level structure-based pharmacophore 20ruids20g of caspase-3-non-peptide complexes: extracting essential pharmacophore features and its application to virtual screening. Chemico-Biological Interactions, 254, 207\u2013220.","journal-title":"Chemico-Biological Interactions"},{"key":"2625_CR23","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1039\/C6MB00229C","volume":"12","author":"TS Tseng","year":"2016","unstructured":"Tseng, T. S., Chuang, S. M., Hsiao, N. W., Chen, Y. W., Lee, Y. C., Lin, C. C., Huang, C., & Tsai, K. C. (2016). Discovery of a potent cyclooxygenase-2 inhibitor, S4, through docking-based pharmacophore screening, in vivo and in vitro estimations. Molecular BioSystems, 12, 2541\u20132551.","journal-title":"Molecular BioSystems"},{"key":"2625_CR24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cbi.2016.05.023","volume":"254","author":"MA Khanfar","year":"2016","unstructured":"Khanfar, M. A., Al-Qtaishat, S., Habash, M., & Taha, M. O. (2016). Discovery of potent adenosine A2a antagonists as potential anti-Parkinson disease agents. Non-linear QSAR analyses integrated with pharmacophore modeling. Chemico-Biological Interactions, 254, 93\u2013101.","journal-title":"Chemico-Biological Interactions"},{"key":"2625_CR25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccell.2015.07.002","volume":"28","author":"R Ronca","year":"2015","unstructured":"Ronca, R., Giacomini, A., Di Salle, E., Coltrini, D., Pagano, K., Ragona, L., Matarazzo, S., Rezzola, S., Maiolo, D., Torrella, R., Moroni, E., Mazzieri, R., Escobar, G., Mor, M., Colombo, G., & Presta, M. (2015). Long-pentraxin 3 derivative as a small-molecule FGF trap for cancer therapy. Cancer Cell, 28, 225\u2013239.","journal-title":"Cancer Cell"},{"key":"2625_CR26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11030-013-9425-2","volume":"17","author":"A Bhadauriya","year":"2013","unstructured":"Bhadauriya, A., Dhoke, G. V., Gangwal, R. P., Damre, M. V., & Sangamwar, A. T. (2013). Identification of dual acetyl-CoA carboxylases 1 and 2 inhibitors by pharmacophore based virtual screening and molecular docking approach. Molecular Diversity, 17, 139\u2013149.","journal-title":"Molecular Diversity"},{"key":"2625_CR27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., & Weissig, H. (2000). The protein data bank. Nucleic Acids Research, 28, 235\u2013242.","journal-title":"Nucleic Acids Research"},{"key":"2625_CR28","doi-asserted-by":"crossref","first-page":"e1002249","DOI":"10.1371\/journal.ppat.1002249","volume":"7","author":"CJ Vavricka","year":"2011","unstructured":"Vavricka, C. J., Li, Q., Wu, Y., Qi, J., Wang, M., Liu, Y., Gao, F., Liu, J., Feng, E., He, J., Wang, J., Liu, H., Jiang, H., & Gao, G. F. (2011). Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition. PLoS Pathogens, 7, e1002249.","journal-title":"PLoS Pathogens"},{"key":"2625_CR29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"JJ Irwin","year":"2005","unstructured":"Irwin, J. J., & Shoichet, B. K. (2005). ZINC\u2014a free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling, 45, 177\u2013182.","journal-title":"Journal of Chemical Information and Modeling"},{"key":"2625_CR30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1039\/C5MB00582E","volume":"12","author":"CK Chang","year":"2016","unstructured":"Chang, C. K., Jeyachandran, S., Hu, N. J., Liu, C. L., Lin, S. Y., Wang, Y. S., Chang, Y. M., & Hou, M. H. (2016). Structure-based virtual screening and experimental validation of the discovery of inhibitors targeted towards the human corona virus nucleocapsid protein. Molecular BioSystems, 12, 59\u201366.","journal-title":"Molecular BioSystems"},{"key":"2625_CR31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1747-0285.2006.00384.x","volume":"67","author":"SL Dixon","year":"2006","unstructured":"Dixon, S. L., Smondyrev, A. M., & Rao, S. N. (2006). PHASE: a novel approach to pharmacophore modeling and 3D database searching. Chemical Biology & Drug Design, 67, 370\u2013372.","journal-title":"Chemical Biology & Drug Design"},{"key":"2625_CR32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","volume":"44","author":"CA Lipinski","year":"2000","unstructured":"Lipinski, C. A. (2000). Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods, 44, 235\u2013249.","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"2625_CR33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jmgm.2010.02.002","volume":"28","author":"Q Huang","year":"2010","unstructured":"Huang, Q., Li, L. L., & Yang, S. Y. (2010). PhDD: a new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility. Journal of Molecular Graphics & Modelling, 28, 775\u2013787.","journal-title":"Journal of Molecular Graphics & Modelling"},{"key":"2625_CR34","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/ci100015j","volume":"50","author":"KS Watts","year":"2010","unstructured":"Watts, K. S., Dalal, P., Murphy, R. B., Sherman, W., Friesner, R. A., & Shelley, J. C. (2010). ConfGen: a conformational search method for efficient generation of bioactive conformers. Journal of Chemical Information and Modeling, 50, 534\u2013546.","journal-title":"Journal of Chemical Information and Modeling"},{"key":"2625_CR35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","volume":"20","author":"SL Dixon","year":"2006","unstructured":"Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006). PHASE: a new engine for pharmacophore perception, 3D QSAR model development and 3D database screening: 1. Methodology and preliminary results. Journal of Computer-Aided Molecular Design, 20, 647\u2013671.","journal-title":"Journal of Computer-Aided Molecular Design"},{"key":"2625_CR36","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/BF02977644","volume":"30","author":"K Bharatham","year":"2007","unstructured":"Bharatham, K., Bharatham, N., & Lee, K. W. (2007). Pharmacophore modeling for protein tyrosine phosphatase 1B inhibitors. Archives of Pharmacal Research, 30, 533\u2013542.","journal-title":"Archives of Pharmacal Research"},{"key":"2625_CR37","first-page":"1","volume":"6","author":"S Rajamanikandan","year":"2016","unstructured":"Rajamanikandan, S., & Srinivasan, P. (2016). Pharmacophore modeling and structure-based virtual screening to identify potent inhibitors targeting LuxP of Vibrio harveyi. Journal of Receptor and Signal Transduction Research, 6, 1\u201316.","journal-title":"Journal of Receptor and Signal Transduction Research"},{"key":"2625_CR38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s13205-011-0006-8","volume":"1","author":"AA Singh","year":"2011","unstructured":"Singh, A. A., Sivakumar, D., & Somvanshi, P. (2011). Cataloguing functionally relevant polymorphisms in gene DNA ligase I: a computational approach. 3 Biotech, 1, 47.","journal-title":"3 Biotech"},{"key":"2625_CR39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"GM Sastry","year":"2013","unstructured":"Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27, 221\u2013234.","journal-title":"Journal of Computer-Aided Molecular Design"},{"key":"2625_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2016.1159986","volume":"17","author":"R Ekhteiari Salmas","year":"2016","unstructured":"Ekhteiari Salmas, R., Unlu, A., Bekta\u015f, M., Yurtsever, M., Mestanoglu, M., & Durdagi, S. (2016). Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies. Journal of Biomolecular Structure & Dynamics, 17, 1\u201317.","journal-title":"Journal of Biomolecular Structure & Dynamics"},{"key":"2625_CR41","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1021\/jm7012425","volume":"51","author":"IG Tikhonova","year":"2008","unstructured":"Tikhonova, I. G., Sum, C. S., Neumann, S., Engel, S., Raaka, B. M., Costanzi, S., & Gershengorn, M. C. (2008). Discovery of novel agonists and antagonists of the free fatty acid receptor 1 (FFAR1) using virtual screening. Journal of Medicinal Chemistry, 51, 625\u2013633.","journal-title":"Journal of Medicinal Chemistry"},{"key":"2625_CR42","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s00044-013-0842-7","volume":"23","author":"AR Muralidharan","year":"2014","unstructured":"Muralidharan, A. R., Selvaraj, C., Singh, S., Nelson Jesudasan, C. A., Geraldine, P., & Thomas, P. (2014). Virtual screening based on pharmacophoric features of known calpain inhibitors to identify potent inhibitors of calpain. Medicinal Chemistry Research, 23, 2445\u20132455.","journal-title":"Medicinal Chemistry Research"},{"key":"2625_CR43","first-page":"1155","volume":"8","author":"SB Nair","year":"2012","unstructured":"Nair, S. B., Fayaz, S. M., & Krishnamurthy, R. G. (2012). In silico prediction of novel inhibitors of the DNA binding activity of FoxG1. Medicinal Chemistry, 8, 1155\u20131162.","journal-title":"Medicinal Chemistry"},{"key":"2625_CR44","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s12010-017-2414-7","volume":"182","author":"V Ramatenki","year":"2017","unstructured":"Ramatenki, V., Dumpati, R., Vadija, R., Vellanki, S., Potlapally, S. R., Rondla, R., & Vuruputuri, U. (2017). Identification of new lead molecules against UBE2NL enzyme for cancer therapy. Applied Biochemistry and Biotechnology, 182, 1497\u20131517.","journal-title":"Applied Biochemistry and Biotechnology"},{"key":"2625_CR45","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1007\/s11051-014-2512-1","volume":"16","author":"F Ramezani","year":"2014","unstructured":"Ramezani, F., Amanlou, M., & Rafii-Tabar, H. (2014). Gold nanoparticle shape effects on human serum albumin corona interface: a molecular dynamic study. Journal of Nanoparticle Research, 16, 2512.","journal-title":"Journal of Nanoparticle Research"},{"key":"2625_CR46","first-page":"1355","volume":"60","author":"AW Schuttelkopf","year":"2004","unstructured":"Schuttelkopf, A. W., & Van Aalten, D. M. F. (2004). PRODRG\u2014a tool for high-throughput crystallography of protein\u2013ligand complexes. Acta Crystallographica, 60, 1355\u20131363.","journal-title":"Acta Crystallographica"},{"key":"2625_CR47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00709-012-0394-6","volume":"250","author":"V Karthick","year":"2013","unstructured":"Karthick, V., Shanthi, V., Rajasekaran, R., & Ramanathan, K. (2013). In silico analysis of drug-resistant mutant of neuraminidase (N294S) against oseltamivir. Protoplasma, 250, 197\u2013207.","journal-title":"Protoplasma"},{"key":"2625_CR48","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.drudis.2010.03.013","volume":"15","author":"SY Yang","year":"2010","unstructured":"Yang, S. Y. (2010). Pharmacophore modeling and applications in drug discovery: Challenges and recent advances. Drug Discovery Today, 15, 444\u2013450.","journal-title":"Drug Discovery Today"},{"key":"2625_CR49","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1128\/JVI.71.5.3385-3390.1997","volume":"71","author":"LV Gubareva","year":"1997","unstructured":"Gubareva, L. V., Robinson, M. J., Bethell, R. C., & Webster, R. G. (1997). Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en. Journal of Virology, 71, 3385\u20133390.","journal-title":"Journal of Virology"},{"key":"2625_CR50","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski, C. A. (2004). Lead- and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technologies, 1, 337\u2013341.","journal-title":"Drug Discovery Today: Technologies"},{"key":"2625_CR51","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1007\/s00894-011-1327-6","volume":"18","author":"K Kalani","year":"2012","unstructured":"Kalani, K., Yadav, D. K., Khan, F., Srivastava, S. K., & Suri, N. (2012). Pharmacophore, QSAR, and ADME based semi-synthesis and in vitro evaluation of ursolic acid analogsfor anticancer activity. Journal of Molecular Modeling, 18, 3389\u20133413.","journal-title":"Journal of Molecular Modeling"},{"key":"2625_CR52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13205-015-0346-x","volume":"6","author":"V Gaddaguti","year":"2016","unstructured":"Gaddaguti, V., Venkateswara Rao, T., & Prasada Rao, A. (2016). Potential mosquito repellent compounds of Ocimum species against 3N7H and 3Q8I of Anopheles Gambiae. 3 Biotech, 6, 26.","journal-title":"3 Biotech"},{"key":"2625_CR53","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1021\/acs.jctc.7b00028","volume":"13","author":"K Sargsyan","year":"2017","unstructured":"Sargsyan, K., Grauffel, C., & Lim, C. (2017). How molecular size impacts RMSD applications in molecular dynamics simulations. Journal of Chemical Theory and Computation, 13, 1518\u20131524.","journal-title":"Journal of Chemical Theory and Computation"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12010-017-2625-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-017-2625-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-017-2625-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T09:27:21Z","timestamp":1603186041000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12010-017-2625-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["2625"],"URL":"https:\/\/doi.org\/10.1007\/s12010-017-2625-y","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]}}}